FORWARD FEATURES CALENDAR

Find us on

Latest News

Biotechnology
MPM Capital, a life science-dedicated venture investment firm, has acquired a minority stake in InformedDNA, the largest independent US provider of genetic counselling and genetic benefits management services.   The investment from MPM’s SunStates Fund will be used to expand InformedDNA’s current genetic benefits utilisation management offerings while also funding the development of new specialty genetic services for the pharmaceutical industry.   "InformedDNA’s genetics expertise combined with MPM’s strong track record in biotechnology, specialty pharmaceutical and medical technology investment made this the perfect match," says InformedDNA chief executive officer David Nixon.   InformedDNA’s flagship enterprise is its national network of
Handshake 2
Scott Kamran is joining Evercore’s investment banking business as a senior managing director in the firm’s technology group.   Kamran will be based in Evercore’s office in the Bay Area and will focus on advising companies in the software sector, as well as in the broader technology industry.   Kamran was most recently a managing director and co-head of global software investment banking at BofA Merrill Lynch. With over 17 years of experience at BofA Merrill Lynch, Merrill Lynch and Lehman Brothers, Kamran has extensive experience advising a broad array of software companies and private equity firms, including advising Teradata
Edmond de Rothschild Investment Partners has made the third investment of BioDiscovery 4, its fourth fund dedicated to life sciences, through its participation in the series B financing round of OncoEthix.   OncoEthix is a Swiss-based oncology drug development company founded in 2009. Edmond de Rothschild Investment Partners participated in the Series B financing round of CHF18m alongside SV Life Sciences and existing investors Index Ventures and Endeavour Vision.   The funds will be used for the clinical development of OTX015, a small molecule inhibitor targeting BET bromodomain proteins 2/3/4. The BET proteins are considered potential cancer targets because of
India flag
Private equity firms obtained exit routes for their investments in 29 Indian companies during the quarter ended June 2013, up 38 per cent over the 21 exits in the same period a year ago, says data from Venture Intelligence, a research service focused on private company financials, transactions and valuations in India.   The exit volumes were also 21 per cent higher than that in the in the immediate previous quarter, which had witnessed 24 exits.   Of the divestitures during the latest quarter, 21 represented complete exits; the remainder partial ones.   Sale of shares in already listed companies
Private equity firm Metric Capital Partners (MCP) has completed its investment in Change of Scandinavia, a leading player in the Nordic lingerie and apparel segment.   Headquartered in Farum, Denmark, Change has a strong focus on comfort, value for money, in-store service levels and large product offering with over 100 custom sizes.   The company was established in 1995 by Claus Jensen, its current chief executive and lead shareholder. Following the opening of its first concept store in Copenhagen in 2001, Change has since enjoyed a strong and steady growth path.   Change benefits from a vertically integrated value chain
Madison Dearborn Partners has agreed to buy Multi Packaging Solutions (MPS), a supplier of print-based specialty packaging, from Irving Place Capital.   Terms of the transaction have not been disclosed.   Multi Packaging Solutions is a manufacturer of high-quality printed folding cartons, labels, and inserts for customers in the healthcare, consumer, and media end markets. MPS has experienced significant growth since Irving Place Capital’s initial investment and now operates 16 manufacturing facilities in the US and Europe, with approximately 2,600 employees worldwide.   “In 2005 we backed entrepreneur Marc Shore with the shared vision of creating a packaging company that
Computer screen
Linedata has added private equity administration functionality to its Back Office platform.   The private equity capability, available in the latest version of transfer agency software Linedata Mshare, will enable users of Linedata Mshare and Linedata Admin Edge to manage the administration of private equity funds, alongside traditional asset management, hedge funds, partnerships and master feeder structures on a single platform.   This is a significant addition to Linedata’s Back Office platform which covers fund accounting, transfer agency and reporting capabilities, with clients in 23 countries across the globe.   Private equity is a significant growth area in the asset
Findis, a French specialist in the wholesale distribution of electrical appliances and kitchen supplies, has acquired Ronzier, a Bordeaux-based wholesaler of electrical appliance and audiovisual products.   Managed by Jean-Christophe Nicodème, Ronzier is based in the Southwest of France. It had a turnover of EUR15m in 2012 and employs 28 people.   Frédéric Jumentier (pictured), president of Findis, says: "Ronzier and Findis have similar vision; we have found in Ronzier’s team the same passion for our profession and the same enthusiasm. With this acquisition, Findis continues its uninterrupted growth for years, based on a distribution model with high added-value, focused
Drugs 2
OncoEthix, the Swiss-based specialist in oncology drug development, has closed a series B financing raising CHF18m (USD19m). SV Life Sciences (SVLS) led the financing, joined by new investor Edmond de Rothschild Investment Partners. Existing investors including Index Ventures and Endeavour Vision also participated in the round.   The proceeds will be used to progress OncoEthix’ novel BET bromodomain inhibitor, OTX015, into Phase II proof of concept studies.   OTX015 is an orally administered synthetic small molecule which targets BET bromodomain proteins 2/3/4. The BET proteins are considered potential cancer targets because of their pivotal role in regulating the transcription of growth-promoting
Lyceum Capital portfolio company Clearswift has seen a seven per cent rise in revenue to GBP20.8m, 85 per cent revenue visibility, of which 94 per cent is recurring though subscription and maintenance along with a 25 per cent increase in average size of new deals.    During this financial year (ending March 2013) Clearswift has seen a 215 per cent increase in EBITDA to GBP4.7m.    The appointment of chief executive officer Heath Davies (pictured) in October 2012, with his strong track record of growing international technology businesses, strengthened the company’s senior management team.  With the backing of the majority

Special Reports

Featured

Events

12 November, 2026 – 8:00 am

Directory Listings